Introduction:
Nosocomial pneumonia is one of the most important
indications for hospital antibiotics because of its relatively high morbidity
and mortality, high frequency of drug-resistant pathogens, and physician
receptivity to new antibiotic therapies.
Using clinical audit data from AMR’s Hospital Antibiotic
Market Guide (HAMG), as well as insight from more than 100 surveyed
infectious disease specialists, this report examines treatment of nosocomial
pneumonia, including the following:
- Analysis of the use of products by treatment intent, line of
therapy, and prescribing physician.
- Prescribing behavior for the top specialties prescribing
antibiotics for nosocomial pneumonia.
- Patient comorbidities, hospitalization outcomes, settings where
treatment occurs, and pathogen distribution.
We analyze the current market place and examine prescribing
drivers for surveyed physicians, reasons for prescribing of key products, unmet
needs, and physician receptivity to emerging antibiotics that can potentially
be used in nosocomial pneumonia.